Eleview™ is an injectable composition patented by Cosmo Pharmaceuticals, NV.
The composition is injected between the mucosal layers of intestinal lumen. Animal studies have demonstrated Eleview™ raises the lesion and separates the mucosal layers for more than 60 minutes.
The composition is stained with Methylene Blue thus allowing a clear differentiation of the tissues and of the margins of the lesions. This gives the endoscopist sufficient time to cut out the growths and reduces the risks that the colon may be perforated in the procedure. Eleview™ is the only product available in the US cleared for marketing by the FDA for this use. Eleview™ was cleared for marketing in U.S. in September 2015, and in June 2016 was cleared in EU. Read More >